{"id":188349,"date":"2020-11-24T14:56:13","date_gmt":"2020-11-24T14:56:13","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=188349"},"modified":"2020-11-24T14:56:13","modified_gmt":"2020-11-24T14:56:13","slug":"vaccinul-dezvoltat-in-rusia-ar-oferi-o-eficienta-de-peste-95-cercetatorii-din-moscova-sustin-ca-nu-au-gasit-niciun-efect-advers-sever-in-randurile-voluntarilor","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=188349","title":{"rendered":"Vaccinul dezvoltat \u00een Rusia ar oferi o eficien\u0163\u0103 de \u201epeste 95%\u201d: Cercet\u0103torii din Moscova sus\u0163in c\u0103 nu au g\u0103sit \u201eniciun efect advers sever\u201d \u00een r\u00e2ndurile voluntarilor"},"content":{"rendered":"<p>\nCreatorii vaccinului anti-COVID-19 din Rusia au anun\u0163at mar\u0163i o eficien\u0163\u0103 de \u201epeste 95%\u201d, procent asem\u0103n\u0103tor vaccinurilor dezvoltate de Pfizer\/BioNTech, Moderna \u015fi AstraZeneca, potrivit Financial Times.<\/p>\n<p>\nInstitutul Gamaleya, condus de Moscova, a declarat c\u0103 datele a circa 19.000 de voluntari indic\u0103 faptul c\u0103 eficien\u0163a vaccinului este de 91,4% la 28 de zile dup\u0103 inoculare \u015fi dep\u0103\u015fe\u015fte pragul de 95% dup\u0103 42 de zile. Alexander Ginsburg, directorul institutului, se a\u015ftept\u0103 ca \u201erata de eficien\u0163\u0103 s\u0103 fie chiar mai mare la trei s\u0103pt\u0103m\u00e2ni dup\u0103 a doua imunizare\u201d.<\/p>\n<p>\nRusia efectueaz\u0103 a\u015fa-zisa faz\u0103 a treia a studiilor clinice \u00een Moscova cu ajutorul a peste 40.000 de voluntari \u015fi desf\u0103\u015foar\u0103 o serie similar\u0103 de teste \u00een Belarus, Venezuela, Emiratele Arabe Unite \u015fi India. Cercet\u0103torii sus\u0163in c\u0103 nu au g\u0103sit \u201eniciun efect advers sever\u201d \u00een r\u00e2ndurile voluntarilor.<\/p>\n<p>\nRusia este prima \u0163ar\u0103 care a anun\u0163at un vaccin de combatere a coronavirusului \u00een luna august. Atunci, pre\u015fedintele Vladimir Putin garantat eficien\u0163a \u00eenainte s\u0103 \u00eenceap\u0103 a treia etap\u0103 a testelor clinice.<\/p>\n<p>\n\u00cen timp ce \u0163\u0103ri precum Arabia Saudit\u0103, Ungaria, Emiratele Arabe Unite, Indonezia, Filipine, Mexic \u015fi unele dintre fostele republici sovietice \u015fi-au ar\u0103tat interesul vis-a-vis de ob\u0163inerea vaccinului, unii exper\u0163i au criticat vehement autorit\u0103\u0163ile ruse pentru faptul c\u0103 s-au gr\u0103bit s\u0103 anun\u0163e o solu\u0163ie la criza sanitar\u0103 f\u0103r\u0103 s\u0103 urmeze pa\u015fi necesari \u00eentr-o astfel de situa\u0163ie.<\/p>\n<p>\nIeri, ultimele rezultate ale gigantului farmaceutic AstraZeneca au oferit o eficien\u0163\u0103 de 70% pentru vaccinul anti-COVID-19 pe care \u00eel dezvolt\u0103 \u00eempreun\u0103 cu Universitatea Oxford.<\/p>\n<p>\nVaccinul prezint\u0103 o eficien\u0163\u0103 de 90% dup\u0103 ce participan\u0163ii au primit o doz\u0103 \u00eentreag\u0103 la aproxiamtiv o lun\u0103 de la prima inoculare, care const\u0103 \u00eentr-o jum\u0103tate de doz\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creatorii vaccinului anti-COVID-19 din Rusia au anun\u0163at mar\u0163i o eficien\u0163\u0103 de \u201epeste 95%\u201d, procent asem\u0103n\u0103tor vaccinurilor dezvoltate de Pfizer\/BioNTech, Moderna \u015fi AstraZeneca, potrivit Financial Times. Institutul Gamaleya, condus de Moscova, a declarat c\u0103 datele a circa 19.000 de voluntari indic\u0103 faptul c\u0103 eficien\u0163a vaccinului este de 91,4% la 28 de zile dup\u0103 inoculare \u015fi dep\u0103\u015fe\u015fte [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[16273,14975,10969,365,14930],"class_list":["post-188349","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cercetatori","tag-efecte-adverse","tag-moscova","tag-rusia","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188349"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188349\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}